Related Experiment Video
Updated: Jan 16, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Multichannel Immune Nanoregulators Suppress Lactic Acid Metabolism and Lactic Acid-Shaped Acidic Microenvironment to
Chao Fang1,2, Qiuxia Peng1, Xiaoying Li3
1Department of Orthopedics and Central Laboratory, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, No. 32, West Second Section, First Ring Road, Chengdu, Sichuan, 610072, China.
Abstract:
Lactic acid (LA) itself and the LA-shaped acidic tumor microenvironment (TME) are identified as root causes of cancer immunosuppression, and no effective strategies address them. Here a multichannel immune nanoregulator is engineered to dampen acidic TME and repolarize non-inflammatory macrophages to uproot this source of cancer immunosuppression, wherein fluorocarbon chains (FC)-modified mesoporous silica (FM) serves as nanoreactors and carriers to in situ synthesize CaO2 and load R848, respectively, followed by liposome coating, anti-CD105 modification and FC-mediated O2 binding in sequence. Both liposome shell and intraparticle FC ensure safe CaO2 delivery. Ultrasound-triggered FC-binding O2 burst and liposomes-destruction-enhanced CaO2 reactions with H+ and H2O produce O2. This process depletes pre-existing H+ and inhibits glycolysis LA production to cut off acidic TME source, and uproots their actions in reshaping cancer immunosuppression, e.g., removing the polarization impetus toward non-inflammatory M2 ones, addressing both symptoms and root causes of cytotoxic T lymphocytes and PD1+ T cells inactivation, etc. The cancer immunosuppression uprooting encourages the anti-tumor efficacy of cancer calcification and intratumoral H2O2 accumulation in the immune nanoregulators especially after anti-CD105-mediated active targeting accumulation. Collectively, this work presents a solution to uproot LA and non-inflammatory macrophages-induced cancer immunosuppression.
Insights
This study introduces a nanoregulator to combat cancer immunosuppression by neutralizing lactic acid and reprogramming macrophages. The nanoregulator effectively targets the acidic tumor microenvironment, restoring anti-tumor immunity.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Research
Background:
- Lactic acid (LA) and the acidic tumor microenvironment (TME) are key drivers of cancer-induced immunosuppression.
- Existing strategies fail to effectively address LA and the acidic TME.
- This creates a need for novel therapeutic approaches to overcome cancer immune evasion.
Purpose of the Study:
- To engineer a multichannel immune nanoregulator capable of dampening the acidic TME and repolarizing immunosuppressive macrophages.
- To address both the symptoms and root causes of cancer immunosuppression driven by LA and non-inflammatory macrophages.
- To enhance the anti-tumor efficacy of existing cancer therapies.
Main Methods:
- Fabrication of a nanoregulator using fluorocarbon chains (FC)-modified mesoporous silica (FM) as nanoreactors.
- In situ synthesis of CaO2 and loading of R848 within the nanoreactors, followed by liposome coating and anti-CD105 modification.
- Ultrasound-triggered oxygen release and CaO2 reactions to neutralize acidity and inhibit LA production.
- Utilizing anti-CD105 for active targeting and accumulation within the tumor.
Main Results:
- The nanoregulator successfully depleted existing H+ and inhibited glycolysis-derived LA production, effectively cutting off the acidic TME.
- Repolarization of non-inflammatory M2 macrophages was achieved, mitigating a key mechanism of cancer immunosuppression.
- Enhanced anti-tumor efficacy was observed, attributed to the nanoregulator's ability to promote cytotoxic T lymphocyte and PD1+ T cell activity.
- Intratumoral H2O2 accumulation and anti-tumor effects were promoted, particularly after targeted delivery.
Conclusions:
- The developed multichannel immune nanoregulator offers a novel strategy to uproot lactic acid and macrophage-induced cancer immunosuppression.
- This approach effectively targets the acidic TME and reprograms the tumor microenvironment to restore anti-tumor immunity.
- The findings present a promising solution for overcoming immune evasion in cancer treatment.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
The Tumor Microenvironment

